Cigna Group $CI Position Lifted by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Key Points

• MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. has increased its holdings in Cigna Group to $16.43 million by acquiring an additional 1,026 shares during Q1.
• Cigna Group's stock is trading at $305.93, reflecting a 1.2% increase in midday trading, with a market capitalization of $81.66 billion.
• The company recently declared a quarterly dividend of $1.51, yielding 2.0%, with a record date set for September 4th.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Cigna Group (NYSE:CI - Free Report) by 2.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,929 shares of the health services provider's stock after acquiring an additional 1,026 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Cigna Group were worth $16,427,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of CI. Price T Rowe Associates Inc. MD raised its position in shares of Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock worth $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock worth $3,834,493,000 after buying an additional 98,715 shares during the last quarter. Dodge & Cox boosted its position in shares of Cigna Group by 1.3% during the 1st quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider's stock worth $2,924,722,000 after purchasing an additional 117,125 shares during the period. GQG Partners LLC boosted its position in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock worth $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Parnassus Investments LLC boosted its position in shares of Cigna Group by 3.1% during the 1st quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider's stock worth $949,357,000 after purchasing an additional 86,602 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 28,526 shares of the firm's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.70% of the company's stock.

Cigna Group Trading Down 1.0%

CI stock traded down $3.16 on Friday, hitting $302.71. 1,105,501 shares of the company were exchanged, compared to its average volume of 1,815,697. Cigna Group has a twelve month low of $256.89 and a twelve month high of $370.83. The business's fifty day moving average is $295.81 and its two-hundred day moving average is $312.08. The stock has a market capitalization of $80.80 billion, a price-to-earnings ratio of 16.52, a price-to-earnings-growth ratio of 0.89 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the prior year, the business earned $6.72 earnings per share. The business's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's dividend payout ratio (DPR) is presently 32.97%.

Analysts Set New Price Targets

Several brokerages have commented on CI. Royal Bank Of Canada reissued an "outperform" rating and issued a $371.00 price target on shares of Cigna Group in a research report on Thursday, June 26th. Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Cantor Fitzgerald restated an "overweight" rating and issued a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Finally, Wells Fargo & Company decreased their price objective on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $374.76.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.